1. Home
  2. SMWB vs LXRX Comparison

SMWB vs LXRX Comparison

Compare SMWB & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

HOLD

Current Price

$6.35

Market Cap

617.6M

Sector

Technology

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.28

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMWB
LXRX
Founded
2007
1995
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
617.6M
703.3M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
SMWB
LXRX
Price
$6.35
$2.28
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
$4.00
$4.15
AVG Volume (30 Days)
1.1M
4.5M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
$11.07
N/A
Revenue Next Year
$11.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
60.24
52 Week Low
$2.22
$1.00
52 Week High
$10.75
$2.68

Technical Indicators

Market Signals
Indicator
SMWB
LXRX
Relative Strength Index (RSI) 54.42 52.23
Support Level $5.73 $2.04
Resistance Level $7.84 $2.53
Average True Range (ATR) 0.51 0.14
MACD -0.15 -0.01
Stochastic Oscillator 25.16 56.98

Price Performance

Historical Comparison
SMWB
LXRX

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: